Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1283095-48-6 | MDL No. : | MFCD22372746 |
Formula : | C16H23NO3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IFDITPFMGGLVMB-UHFFFAOYSA-N |
M.W : | 309.42 | Pubchem ID : | 52951550 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.69 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 87.58 |
TPSA : | 67.01 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.38 cm/s |
Log Po/w (iLOGP) : | 3.5 |
Log Po/w (XLOGP3) : | 2.55 |
Log Po/w (WLOGP) : | 3.06 |
Log Po/w (MLOGP) : | 2.23 |
Log Po/w (SILICOS-IT) : | 3.68 |
Consensus Log Po/w : | 3.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.34 |
Solubility : | 0.14 mg/ml ; 0.000454 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.6 |
Solubility : | 0.0769 mg/ml ; 0.000249 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.56 |
Solubility : | 0.0862 mg/ml ; 0.000279 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.74 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | at 22℃; | PREPARATION 2tert-Butyl spiro[4,5-dihydrothieno[2,3-c]pyran-7,4'-piperidine]-1'-carboxylate; Spiro[4,5-dihydrothieno[2,3-c]pyran-7,4'-piperidine] (60 g, 286.6 mmol) in 2-methyltetrahydrofuran (600 mL) is stirred at 22° C. for 10 min. Then, tert-butoxycarbonyl tert-butyl carbonate (65.6 g, 301 mmol) in 2-methyltetrahydrofuran (300 mL) is added dropwise. After 12 hr., an aqueous solution of sodium chloride (250 mL) is added and the organic layer is separated. The aqueous layer is washed twice with 2-methyltetrahydrofuran (2.x.50 mL) and the organic layers are combined and washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to give the title compound in 99percent yield. MS (m/z): 310 (M+1). |
99% | for 12 h; | Spiro[4,5-dihydrothieno[2,3-c]pyran-7,4'-piperidine] (60 g, 286.6 mmol) in 2- methyltetrahydrofuran (600 mL) is stirred at 22°C for 10 min. Then, tert- butoxycarbonyl tert-butyl carbonate (65.6 g, 301 mmol) in 2-methyltetrahydrofuran (300 mL) is added dropwise. After 12 hours, aqueous solution of sodium chloride (250 mL) is added and the organic layer separated. Then aqueous layer is washed twice with 2-methyltetrahydrofuran (2 x 50 mL) and the organic layers are combined and washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to give the title compound in 99percent yield. MS (m/z): 310 (M+l). |
[ 165947-52-4 ]
tert-Butyl 4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate
Similarity: 0.71
[ 230301-73-2 ]
tert-Butyl 6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate
Similarity: 0.70
[ 203663-30-3 ]
tert-Butyl 2-formyl-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate
Similarity: 0.69
[ 173943-92-5 ]
Ethyl 4-hydroxy-4-(2-(2-hydroxyethyl)phenyl)piperidine-1-carboxylate
Similarity: 0.66
[ 193537-14-3 ]
Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate
Similarity: 0.64
[ 165947-52-4 ]
tert-Butyl 4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate
Similarity: 0.71
[ 230301-73-2 ]
tert-Butyl 6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate
Similarity: 0.70
[ 203663-30-3 ]
tert-Butyl 2-formyl-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carboxylate
Similarity: 0.69
[ 193537-14-3 ]
Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate
Similarity: 0.64
[ 949922-62-7 ]
tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate
Similarity: 0.63
[ 173943-92-5 ]
Ethyl 4-hydroxy-4-(2-(2-hydroxyethyl)phenyl)piperidine-1-carboxylate
Similarity: 0.66
[ 952681-82-2 ]
2-(1'-(tert-Butoxycarbonyl)spiro[chroman-2,4'-piperidine]-4-yl)acetic acid
Similarity: 0.63
[ 333954-86-2 ]
tert-Butyl 4-(4-cyanophenoxy)piperidine-1-carboxylate
Similarity: 0.62
[ 1000931-04-3 ]
1-Boc-3-Hydroxy-4-phenylpiperidine
Similarity: 0.62
[ 95798-23-5 ]
Benzyl 4-hydroxypiperidine-1-carboxylate
Similarity: 0.62
[ 952681-82-2 ]
2-(1'-(tert-Butoxycarbonyl)spiro[chroman-2,4'-piperidine]-4-yl)acetic acid
Similarity: 0.63
[ 84060-08-2 ]
1'-Boc-1,2-dihydro-2-oxo-spiro[4H-3,1-benzoxazine-4,4'-piperidine]
Similarity: 0.60
[ 1251015-16-3 ]
tert-Butyl 5-bromo-2H-spiro[benzofuran-3,4'-piperidine]-1'-carboxylate
Similarity: 0.59
[ 889139-52-0 ]
tert-Butyl 1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-carboxylate hydrochloride
Similarity: 0.58
[ 849106-20-3 ]
tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4'-piperidine]-1'-carboxylate
Similarity: 0.58